Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MKS Enterprise is a U.S. private company that has sold consumer health products online, including honey-based sexual enhancement products marketed under the Dose Vital/Vital Honey name. The company appears to operate as a distributor or marketer rather than a drug development biotechnology or pharmaceutical company. Publicly available evidence indicates FDA enforcement action against the company in 2022 related to products found to contain undeclared tadalafil and marketed with unlawful drug claims. There is no clear evidence that MKS Enterprise has a therapeutic R&D pipeline, proprietary drug platform, or clinical-stage development programs. For biotech analyst purposes, this entity is best characterized as a small commercial seller of regulated health-related products rather than a life sciences innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MKS Enterprise.